Marijuana Datajam: Aurora’s Q4 puts them on top
The Aurora Cannabis Company (TSX:ACB)(NASDAQ:ACB) market action following their 2019 year end financials has been downright literary. In a mixed triumph straight out of a […]
TSX:TGOD
Can’t-O-P-rate: WEED’s dismal quarter in charts
Canopy’s June quarter didn’t give us any indication that they’re ready to create cannabis at margin or make a jump to a reasonable rate of growth.
The Cannazeitgeist, June 11th 2019
Featuring @iandawkins on CDN Cannabis banking, gnashing of teeth among the $N army, and confusion over the $TGOD spinout from @mmjinvesting and @Bartonius
Bruised up: FH reads the Harvest Moon Cannabis report on Aurora so you don’t have to
@BettingBruiser’s report on $ACB’s portfolio is a great read if you can get through it. We broke out a summary for a pre-earnings call amuse-bouche.
Is Aurora Cannabis’ bid for Whistler Medical Marijuana just an opener?
$ACB’s made a $175M all-stock bid for private Whistler Medical after unloading some $TGOD. $CRON may have something to say about this before it’s over.